FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

BT Group maintains FY27 outlook after steady first-quarter results

BT Group said first-quarter trading was in line with plan, with record fibre connections, stronger 5G+ coverage and reaffirmed FY27 guidance...

3i Group reports strong start to FY2027 as Action maintains growth

3I Group Plc reported increased NAV per share, strong Action trading and progress on its share buyback programme...

Airtel Africa Q1 revenue rises 31% as customer growth accelerates

Airtel Africa reported stronger first-quarter revenue, EBITDA and customer growth, alongside continued investment in network expansion and Airtel Money...

RELX reports 7% revenue growth, reaffirms 2026 outlook

Relx Plc reported higher first-half revenue, operating profit and earnings per share, and reiterated its outlook for continued underlying growth...

Centrica reports 2026 half-year results and declares 2.0p dividend

Centrica Plc has outlined its 2026 interim dividend, financial calendar and availability of its half-year results on its corporate website...

Astrazeneca secures EU approval for Etcamah in ER-positive breast cancer

Astrazeneca Plc has secured European Union approval for Etcamah in combination therapy for ER-positive, HER2-negative advanced breast cancer...

Fresnillo gold output rises 13.8% as full-year outlook remains on track

Fresnillo reported higher quarterly gold production, outlined first-half trends and reaffirmed full-year 2026 production guidance...

Smiths Group completes £760m pension buy-in with M&G

Smiths Group has completed a £760 million buy-in for its pension scheme, covering more than 10,000 members and fully insuring c.17,000 members...

Compass Group reports continued strong quarterly revenue growth

Compass Group reported 7.1% organic revenue growth in the third quarter and said it remains on track for another year of strong earnings growth...

GSK filing accepted by EMA for Bexsero booster label update

GSK says the EMA has accepted a submission to update Bexsero’s label to include a single-dose booster for older previously vaccinated individuals...

Experian reports 7% organic revenue growth in first quarter

Experian reported first-quarter revenue growth of 10% at actual exchange rates and said full-year expectations remain unchanged...

DCC reports year-on-year growth in first quarter

DCC said first-quarter trading was ahead of the prior year, with outlook, development activity and a proposed name change also outlined...

Convatec names NED and outlines CFO transition

Convatec has outlined finance leadership changes, appointed Tobias Hestler as a Non-Executive Director and reaffirmed its 2026 expectations...

Rio Tinto maintains 2026 guidance as iron ore sales and lithium output rise

Rio Tinto reported higher first-half copper equivalent production, with stronger copper and lithium output and unchanged full-year guidance...

Barratt Redrow reports FY26 trading update and launches £386m buyback

Barratt Redrow has reported FY26 trading performance in line with expectations and announced a new share buyback programme...

BP expects stronger Q2 2026 margins as net debt falls

Bp Plc has provided a second quarter 2026 trading statement, outlining expected production, refining and net debt movements...

Taylor Wimpey appoints Sarah Warby as independent non-executive director

Taylor Wimpey has appointed Sarah Warby as an independent non-executive director and confirmed further board changes...

Astrazeneca secures global rights to Zegfrovy in EGFR-mutated lung cancer

Astrazeneca Plc has agreed an exclusive licence with Dizal Pharmaceutical for Zegfrovy, adding a novel oral EGFR inhibitor to its oncology portfolio...

GSK reports positive interim AZUR-1 results for Jemperli in rectal cancer

GSK has reported positive interim AZUR-1 results for Jemperli in dMMR/MSI-H locally advanced rectal cancer, with the study meeting its primary objective...

Polar Capital Technology Trust NAV doubles as assets reach £7.3bn

Polar Capital Technology Trust has reported full-year figures showing higher net assets, NAV per share and share price for the year ended 30 April.....
Search

Funds

FTSE 100

BT Group maintains FY27 outlook after steady first-quarter results

BT Group said first-quarter trading was in line with plan, with record fibre connections, stronger 5G+ coverage and reaffirmed FY27 guidance...

3i Group reports strong start to FY2027 as Action maintains growth

3I Group Plc reported increased NAV per share, strong Action trading and progress on its share buyback programme...

Airtel Africa Q1 revenue rises 31% as customer growth accelerates

Airtel Africa reported stronger first-quarter revenue, EBITDA and customer growth, alongside continued investment in network expansion and Airtel Money...

RELX reports 7% revenue growth, reaffirms 2026 outlook

Relx Plc reported higher first-half revenue, operating profit and earnings per share, and reiterated its outlook for continued underlying growth...

Centrica reports 2026 half-year results and declares 2.0p dividend

Centrica Plc has outlined its 2026 interim dividend, financial calendar and availability of its half-year results on its corporate website...

Astrazeneca secures EU approval for Etcamah in ER-positive breast cancer

Astrazeneca Plc has secured European Union approval for Etcamah in combination therapy for ER-positive, HER2-negative advanced breast cancer...

Fresnillo gold output rises 13.8% as full-year outlook remains on track

Fresnillo reported higher quarterly gold production, outlined first-half trends and reaffirmed full-year 2026 production guidance...

Smiths Group completes £760m pension buy-in with M&G

Smiths Group has completed a £760 million buy-in for its pension scheme, covering more than 10,000 members and fully insuring c.17,000 members...

Compass Group reports continued strong quarterly revenue growth

Compass Group reported 7.1% organic revenue growth in the third quarter and said it remains on track for another year of strong earnings growth...

GSK filing accepted by EMA for Bexsero booster label update

GSK says the EMA has accepted a submission to update Bexsero’s label to include a single-dose booster for older previously vaccinated individuals...

Experian reports 7% organic revenue growth in first quarter

Experian reported first-quarter revenue growth of 10% at actual exchange rates and said full-year expectations remain unchanged...

DCC reports year-on-year growth in first quarter

DCC said first-quarter trading was ahead of the prior year, with outlook, development activity and a proposed name change also outlined...

Convatec names NED and outlines CFO transition

Convatec has outlined finance leadership changes, appointed Tobias Hestler as a Non-Executive Director and reaffirmed its 2026 expectations...

Rio Tinto maintains 2026 guidance as iron ore sales and lithium output rise

Rio Tinto reported higher first-half copper equivalent production, with stronger copper and lithium output and unchanged full-year guidance...

Barratt Redrow reports FY26 trading update and launches £386m buyback

Barratt Redrow has reported FY26 trading performance in line with expectations and announced a new share buyback programme...

BP expects stronger Q2 2026 margins as net debt falls

Bp Plc has provided a second quarter 2026 trading statement, outlining expected production, refining and net debt movements...

Taylor Wimpey appoints Sarah Warby as independent non-executive director

Taylor Wimpey has appointed Sarah Warby as an independent non-executive director and confirmed further board changes...

Astrazeneca secures global rights to Zegfrovy in EGFR-mutated lung cancer

Astrazeneca Plc has agreed an exclusive licence with Dizal Pharmaceutical for Zegfrovy, adding a novel oral EGFR inhibitor to its oncology portfolio...

GSK reports positive interim AZUR-1 results for Jemperli in rectal cancer

GSK has reported positive interim AZUR-1 results for Jemperli in dMMR/MSI-H locally advanced rectal cancer, with the study meeting its primary objective...

Polar Capital Technology Trust NAV doubles as assets reach £7.3bn

Polar Capital Technology Trust has reported full-year figures showing higher net assets, NAV per share and share price for the year ended 30 April.....
Search

Funds

FTSE 100

FTSE 100

Funds